Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00072631
Status:
COMPLETED
Last Update Posted:
2018-02-08
First Post:
2003-11-05
Brief Title:
Erlotinib Tarceva Trademark OSI-774 in Treating Patients With Advanced Non-Small Cell Lung Cancer
Sponsor:
OSI Pharmaceuticals
Organization:
Astellas Pharma Inc